Skip to main content
PepStack
Blutwerte · Marker

Osteocalcin

Bone Gla Protein · BGP · Osteocalcin

Knochen & MineralogieZeitabhängig
Einheit:
ng/mL
Abbreviation
OC / BGP

Osteocalcin quantifies the concentration of a bone-derived hormone involved in bone formation and mineralization.

Reference Ranges

Reference
11–46ng/mL
11
46
LowNormalHigh
Reference
Unit · ng/mL

Levels vary with age and sex; higher in children and adolescents due to growth.

Overview

Übersicht

Osteocalcin, also known as Bone Gla Protein (BGP), is a non-collagenous protein hormone found in bone and dentin, synthesized by osteoblasts. It plays a crucial role in bone mineralization and calcium ion homeostasis. Osteocalcin is a vitamin K-dependent protein, which requires carboxylation to become biologically active. Researchers have observed that osteocalcin is involved in the regulation of bone turnover and is considered a marker of bone formation. Clinically, osteocalcin levels are used to assess bone metabolism and are particularly relevant in conditions such as osteoporosis, where bone density and strength are compromised. Elevated levels of osteocalcin may indicate increased bone turnover, which can be seen in metabolic bone diseases, hyperparathyroidism, and during periods of rapid bone growth. Conversely, reduced levels may suggest impaired bone formation or vitamin K deficiency. In the context of athletic performance and biohacking, osteocalcin has been studied for its potential role in energy metabolism and muscle function, with some evidence suggesting it may influence glucose metabolism and fat mass. However, its exact impact on athletic performance and longevity remains an area of active research. Caveats in measuring osteocalcin include its diurnal variation, with levels peaking in the early morning, and potential interference from vitamin K status. Fasting is not typically required, but consistent timing of sample collection is recommended for accurate monitoring. Factors such as age, sex, and hormonal status can also influence osteocalcin levels, necessitating careful interpretation of results in clinical practice.

Klinische Bedeutung

Elevated osteocalcin levels may indicate increased bone turnover or metabolic bone disease, while reduced levels can suggest impaired bone formation or vitamin K deficiency.

Dynamics

Trend Interpretation

Rising Values

Progressively rising osteocalcin may suggest increased bone turnover or metabolic bone disease. Re-test in 3 months if levels are significantly elevated.

Falling Values

Falling osteocalcin levels may indicate reduced bone formation or effective treatment of high bone turnover.

Re-test Interval

3 months if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Metabolic bone disease
  • Hyperparathyroidism
  • Rapid bone growth
  • Bone healing post-fracture
  • Hyperthyroidism
Cause

Low Levels

  • Vitamin K deficiency
  • Hypoparathyroidism
  • Osteoporosis
  • Chronic kidney disease
  • Malnutrition
Protocol

How to Optimize

Lever

Lifestyle

  • Regular weight-bearing exercise
  • Adequate sun exposure for vitamin D
  • Smoking cessation
Lever

Nutrition

  • Increase dietary vitamin K
  • Consume calcium-rich foods
  • Ensure adequate protein intake
Lever

Supplementation

  • Vitamin K2
  • Vitamin D3
  • Calcium

Note:

Consult a healthcare provider before starting new supplements, especially if on anticoagulant therapy.

Testing Guidelines

✓Fasting Not Required
🕐Time-Sensitive

Levels peak in early morning; consistent timing recommended.

Testing Frequency

Annually for those at risk of osteoporosis, more frequently if monitoring treatment response.

Interfering Factors

  • Recent bone fracture
  • Vitamin K intake
  • Hormonal fluctuations

Related Peptides & Hormones

Vitamin D

Correlated with

hormone or peptide

Open Research Questions

Current research suggests that the role of osteocalcin in cardiovascular risk and its relationship with vitamin K status remain unclear, particularly regarding reference ranges and optimal targets. Researchers have not yet established the mechanisms by which osteocalcin influences adolescent psychopathology, indicating a need for further exploration of its role in stress responses. Additionally, clinical questions remain unanswered about the specific thresholds of osteocalcin that predict various psychiatric disorders and the potential confounding factors influencing these associations.

46 Research Publications

581

Total Citations

14

Human/RCT

2.1

Avg. Influence

2024

Latest

Sort
Filter
#01

Melatonin: Another avenue for treating osteoporosis?

ReviewInfluence2.0
131
Researchers found that melatonin may play a significant role in bone metabolism by promoting new bone formation and suppressing bone loss. They observed that melatonin activates specific receptors that enhance the expression of osteocalcin, a key biomarker for bone health. This study suggests that melatonin could be a novel approach for preventing and treating osteoporosis.
View on PubMed
#02

Isolation of acetic, propionic and butyric acid-forming bacteria from biogas plants.

AnimalInfluence3.0
81
View on PubMed
#03

News on biomarkers in CKD-MBD.

Mazzaferro Sandro, et al. · Seminars in nephrology · 2014

Review
56
Researchers evaluated the significance of bone markers, including osteocalcin, in chronic kidney disease-mineral and bone disorders. They found that osteocalcin is involved in glucose and energy metabolism, and its activation requires vitamin K, which is often deficient in renal patients.

Key findings

  1. 01Researchers observed that classic bone markers like parathyroid hormone and alkaline phosphatase are crucial for assessing kidney-related bone disorders.
  2. 02They found that noncollagenous proteins, such as matrix Gla protein and osteocalcin, are linked to calcification and energy metabolism, but require vitamin K to function properly.
  3. 03The study emphasized the need for more research on the diagnostic potential of small integrin-binding ligand N-linked glycoproteins in CKD-related conditions.
View on PubMed
#04

Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway.

AnimalInfluence3.0
43
Researchers explored the effects of uncarboxylated osteocalcin on glucose and lipid metabolism in KKAy mice. The study found that uncarboxylated osteocalcin significantly enhanced insulin sensitivity and improved hyperglycemia. Additionally, it was observed to alleviate hepatic steatosis and dyslipidemia in the mice.
View on PubMed
#05

Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases.

ReviewInfluence2.0
38
Researchers reviewed the association of osteocalcin with cardiovascular and metabolic diseases, finding that lower circulating levels are linked to increased cardiovascular risk and insulin resistance. The study highlights the potential of osteocalcin as a biomarker for these conditions.
View on PubMed
#06

Aptamer selection and aptasensor construction for bone density biomarkers.

In Vitro
27
This research focused on developing aptamer-based assays for detecting bone density biomarkers, including osteocalcin. Researchers successfully selected high-affinity aptamers for osteocalcin, achieving a detection limit of 0.4 pg/ml. The study highlights the potential of aptasensors to improve the specificity and robustness of osteoporosis diagnostics.
View on PubMed
#07

Serum bone biomarkers and oral/systemic bone loss in humans.

HumanInfluence2.0
25
Researchers found that serum osteocalcin levels were significantly associated with systemic bone mineral density loss in post-menopausal women. Changes in serum osteocalcin were also linked to loss of alveolar bone density and height. This study highlights the role of serum bone biomarkers in tracking both systemic and localized bone loss.
View on PubMed
#08

Circulating FABP4, nesfatin-1, and osteocalcin concentrations in women with gestational diabetes mellitus: a meta-analysis.

Meta-AnalysisInfluence1.0
22
This meta-analysis investigated circulating levels of osteocalcin in women with gestational diabetes mellitus (GDM). Researchers found that osteocalcin levels were higher in women with GDM compared to healthy controls, although the predictive interval suggested variability. The study indicates that while osteocalcin is elevated in GDM, FABP4 may be a more suitable biomarker for identifying women at risk.
View on PubMed
#09

Broad application prospects of bone turnover markers in pediatrics.

Review
21
Researchers emphasized the importance of bone turnover markers like osteocalcin in pediatric medicine. They found that these markers can assist in diagnosing and monitoring bone metabolic disorders in children. This study highlights the need for further exploration of BTMs in pediatric populations.
View on PubMed
#10

Correlations of DKK1 with pathogenesis and prognosis of human multiple myeloma.

HumanInfluence2.0
17
This study investigated the correlation of Dickkopf-1 (DKK1) with multiple myeloma and its impact on osteocalcin levels. Researchers found that high DKK1 expression was associated with reduced osteocalcin deposition and shorter survival times in patients, suggesting its potential as a biomarker for prognosis.
View on PubMed

Clinical Trials (15)

15

Total Trials

1,969

Total Enrolled

Retrospective Monocentric Evaluation of Biomarkers Associated With Bone, Muscle and Energy Metabolism

NCT07454252RECRUITING
Sponsor

IRCCS San Raffaele

Enrollment

1,000

Started

2025

Primary outcome

Evaluate circulating levels of osteocalcin, the main non-collagenous protein bound to hydroxyapatite (HAP) and synthesized by osteoblasts-thus considered a biomarker of bone formation-in relation to circulating vitamin D, an endocrine factor involved

Bone RemodelingEnergy Metabolism

Effects of Increased Greek Yogurt Consumption in Senior Adults

NCT06530394COMPLETED
Sponsor

Brock University

Enrollment

40

Started

2024

Primary outcome

Serum concentrations of osteocalcin

OsteoporosisInflammation

Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes

NCT05922462RECRUITING
Sponsor

Brock University

Enrollment

40

Started

2023

Primary outcome

Osteocalcin

Bone Growth AbnormalInflammation

Bone Turnover in Type 2 Diabetes and Non-diabetes Controls (DiaMarv)

NCT05585697COMPLETED
Sponsor

University of Aarhus

Enrollment

52

Started

2022

Primary outcome

Plasma concentration of Osteocalcin

Diabetes Mellitus, Type 2Bone Fragile

Prevention of Glucocorticoid Induced Impairment of Bone Metabolism

NCT04767711COMPLETED
Sponsor

Sahlgrenska University Hospital

Enrollment

50

Started

2022

Primary outcome

Change in bone turnover marker serum osteocalcin

Bone Loss

Prospective Study of Patients Treated for Bone and Joint Infection (BJI) Due to Staphylococcus Aureus, Aiming at Identifying Biomarkers of Diagnosis Interest in Chronic BJI

NCT04583241TERMINATED
Sponsor

Hospices Civils de Lyon

Enrollment

28

Started

2020

Primary outcome

Dosages of serum osteocalcin

Bone and Join Infection (BJI)Periprosthetic Joint Infection (PJI)

Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging

NCT04669782TERMINATED
Sponsor

University of Milano Bicocca

Enrollment

99

Started

2020

Primary outcome

Circulating levels of GluOC

Bone Metabolism DisorderAging DisorderOsteoporosis

Quercetin's Effect on Bone Health and Inflammatory Markers

NCT05371340COMPLETED
Sponsor

Kennesaw State University

Enrollment

33

Started

2019

Primary outcome

Osteocalcin ng/mL

Osteoporosis, Postmenopausal

Biocomparison Study

NCT01638182COMPLETED
Sponsor

Maastricht University Medical Center

Enrollment

81

Started

2011

Primary outcome

carboxylation of osteocalcin

Bone HealthVascular Health

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

NCT00963417COMPLETED
Sponsor

ETOP IBCSG Partners Foundation

Enrollment

119

Started

2009

Primary outcome

Serial serum levels of C-telopeptide, osteocalcin, and bone-specific alkaline phosphatase

Breast CancerOsteoporosis

Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal Women

NCT00789425Phase 2COMPLETED
Sponsor

BioActor

Enrollment

64

Started

2008

Primary outcome

Serum levels of Osteocalcin and CTX will be used as bone turnover markers

OsteoporosisOsteopenia

Melatonin Osteoporosis Prevention Study

NCT01152580Phase 1COMPLETED
Sponsor

Duquesne University

Enrollment

19

Started

2008

Primary outcome

The Effect of Melatonin (3 mg) or Placebo on the Mean Change in Serum Osteocalcin (OC) Levels in Women After 6 Months, as Compared to Baseline

OsteoporosisOsteopenia

The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients

NCT01235325Phase 4COMPLETED
Sponsor

University College Cork

Enrollment

70

Started

2008

Primary outcome

% Undercarboxylated osteocalcin

SupplementationBone HealthCrohn's Disease

Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients

NCT00912938Phase 4UNKNOWN
Sponsor

Korean Breast Cancer Study Group

Enrollment

237

Started

2007

Primary outcome

Urinary NTX and serum osteocalcin will be assessed at baseline, 3, 6, 9, and 12 months and when unexpected skeletal related events is detected.

Metastatic Breast Cancer

The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers

NCT02767089Phase 1COMPLETED
Sponsor

Pfizer

Enrollment

37

Started

2005

Primary outcome

Characterize the dose-response effect of prednisone 2.5, 5, 10, 20, 40 and 60 mg on osteocalcin

Healthy Adults

Publication Trend

Research publications about Osteocalcin over time

10total
1
'19
1
'22
1
'23
3
'24
4
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer